Since 2019, mandatory digital labeling of goods, including in the pharmaceutical industry, has been set in motion. According to public sources, the share of illegal drug trafficking in the Russian market is up to 10%. Launch of labeling will finally benefit all participants in the supply chain: both the state and the manufacturer, pharmacies, and consumers.

On November 14, Marina Zabalueva, Head of the Department for interaction with public authorities of NANOLEK, spoke at the conference “Labeling in the pharmaceutical industry” where she shared details on the current situation with introduction of labeling at our plant. To share experience with colleagues, to describe challenges, ways of overcoming them, to learn how other participants of the supply chain are doing, to find joint solutions - the meeting was organized not just for talking, but for achieving the desired outcome.

Two days before, on November 12, parliamentarians initiated a bill at the State Duma to provide a transitional 6-month period for the introduction of mandatory drug labeling: A monitoring of readiness for labeling showed that most pharmacies are not yet ready for a change to the new system effective from January 1, 2020. The conference participants supported this decision since millions of lives are at stake behind the technical process, therefore there is absolutely no room for mistakes.